
jan pm et
summari lead consum product compani global tissu person care health care
brand includ huggi pull-up kotex depend kleenex scott
price-to-earnings oper ep
risk assess reflect gener static demand
household person care product
usual significantli affect chang
economi geopolit factor
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
look sale rise
billion billion
reflect organ sale growth
neutral foreign currenc exchang
mostli higher volum price
pressur competit promot
environ develop market see
benefit easier
comparison new product launch
gain asian latin american
busi expect sale growth
expect ebitda margin
reflect acceler
save restructur effort follow
spin-off health care busi
halyard new cost reduct
activ includ cut work forc
partial off-set lower
price higher input cost increas
spend market research
follow share repurchas forecast
oper ep
respect
one-tim item period
long-term sale growth like
help expans non-tradit
categori compani focu
emerg market well innov
allow rais effect price howev
see near-term ep growth neg
impact rise promot competit
addit slow econom growth global
market unfavor demograph
low birth rate limit growth babi
care busi view announc
would reduc total workforc
close ten manufactur facil
look exit sell small low-margin
busi effort cut cost
risk recommend target price
innov less success
expect unfavor foreign currenc
target price
trade rang recent
indic dividend yield despit
sale margin benefit volum growth
increas cost save see valuat
restrict rise promot competit
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview best known brand kleenex scott huggi kotex
sell consum product countri oper broadli diversifi
enterpris made major transit begin earli transform global
consum product compani compani develop health care busi
acquisit technol medic product ballard medic product safeskin corp reflect
strateg acquisit strateg divestitur sinc becom lead global
manufactur tissu person care health care product manufactur countri
distribut sharehold outstand share neenah paper inc form
facilit spin-off fine paper technic paper busi canadian pulp
classifi busi three report global segment sale
consum tissu k-c profession sale geograph region
north america europ asia latin america wal-mart store inc
singl largest custom account net sale
corpor strategi introduc new strateg plan call global busi
gbp involv priorit growth opportun appli greater financi disciplin
global oper compani plan continu execut global busi plan annual
goal establish gbp top-lin growth ep growth mid- high-singl digit
oper margin improv basi point capit spend net sale
improv basi point dividend increas line ep growth also
gbp capit alloc focus target expans activ increas emphasi
innov cost reduct
support margin improv target made cost reduct system part
busi model compani focus reduc cost everywher program aim
promot best practic regard cost work capit manag across compani
realiz save well streamlin manufactur administr oper
primarili north american europ million million million
million million million compani aim achiev
million save
impact signific develop novemb complet tax free spin-off
health care busi known halyard health hyh nr manag indic strateg
fit growth prioriti busi chang time move would allow
health optim perform flexibl pursu value-cr opportun
also expect abl sharpen focu consum non-health care profession
brand sharehold receiv one share hyh common stock everi eight share
common stock held close trade octob record date spin-off
initi organiz restructur order improv effici off-set impact
strand overhead cost result spin-off health care busi octob
compani complet restructur total cost million tax million
pre-tax cumul pre-tax save expect million million end
financi trend net sale declin reflect unfavor impact
chang foreign currenc exchang rate net sale fell unfavor foreign
currenc exchang impact organ sale grew driven higher volum net price flat
oper margin expand million save cost reduct program
million headcount cost reduct million lower input cost
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli overvalu
neutral sinc januari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
neutral fundament outlook
household product sub-industri next
consum confid continu
trend higher thank part modest
improv employ market expect
wage growth improv slowli although
remain low level think abil
compani fend market share gain
supplier lower-pr product depend
part market support provid
scope success product
market brand compani vie
market share privat label store brand
product view competit well
leverag larg retail often
limit gener price increas household
product howev expect
reduct cost see
opportun margin expans raw
materi use household product
pulp resin number compani continu
look way oper effici
part off-set pressur higher input
household product sub-industri remain
competit view given matur
develop countri numer
compani vy captur market share
chang lifestyl develop
intern market like provid
secular growth opportun
calcul expect emerg market see
rise demand packag product
consum could previous afford
notwithstand slight deceler
econom growth rate certain market
past year
multi-national compani expect strong
 dollar reduc foreign sale
base index
five-year market price perform jan
sale translat dollar
given current exchang rate howev
actual magnitud impact depend
market manufactur sell
actual currenc movement extent
year date june
rise
compar rise
note procter gambl
weight
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
vs estim lower expect tax rate
organ net sale declin wider expect north american result
hurt categori soft increas competit reduc
promot despit growth develop emerg market see
margin benefit cost save partli off-set rise input cost inflat /j
corpor name larri allgaier group presid
north america report mike hsu presid chief
oper offic new role effect april allgaier
lead billion north american consum busi trust
brand huggi cottonel depend prior join k-c allgaier
held senior leadership role mar inc join
recent presid newli form mar petcar veterinari health
group presid billion north america petcar
busi role deliv signific growth market share
improv prior mar inc allgaier global head novarti
counter medicin respons brand
kimberly-clark corpor rais target
price appli price-to-earnings line kmb
averag ep estim cut unfavor
fx set ep adjust ep vs
estim organ sale growth line estim
support sequenti improv volum despit unfavor
price/mix see intens price competit emerg market
limit sale growth expect margin benefit acceler
cost cut volum leverag /j agnes
et cfra keep hold recommend share
kimberly-clark corpor lower target
price price-to-earnings in-lin kmb averag
ep estim decreas ep
estim ep vs
estim see valuat ep growth hurt unfavor constant
currenc sale growth trend across busi segment reflect difficult
comparison increas competit howev still think growth
achiev continu low input cost benefit cost
cut restructur /j agnes
analyst research note compani news
corpor keep target
ep estim compar five-year forward averag price-to-earnings
balanc slower sale growth outlook expect margin
expans driven restructur effort rais ep estim
set report oper ep
vs consensu plan cut workforc
close ten factori exit sell
low margin busi effort cut cost see posit
kimberly-clark corpor keep target
price-to-earnings near mid-point rang
forward ep estim adjust ep vs
estim organ sale slightli posit line
estim volum growth off-set lower price
intens competit environ yet see sale support comp eas
margin widen expect cost save reduc
market research spend see margin benefit somewhat
restrict rise input cost /joseph agnes
et cfra keep hold recommend share
trim target price
appli price-to-earnings line averag forward
ep estim lower ep estim
ep vs
estim organ growth fell expect drag
declin consum product reflect categori soft less promot
shipment increas competit margin pressur rise input
cost price competit expect increas focu cost cut
appoint tarun raman region market director
asia pacif region undertak duti babi care segment replac
rahul asthana taken new role australia prior move
raman countri market director brand sinc base
malaysia prior also held market leadership role
brand pizza hut held sever
posit marico limit meanwhil asthana held
role sinc take addit duti digit
e-commerc follow restructur market duti new structur saw
asthana region market director sector leader asean take
role market director babi child care busi
corpor announc jeffrey melucci elect
compani board director senior vice presid gener counsel
effect septemb report chairman ceo thoma falk
melucci respons legal government affair
compani serv compani execut leadership melucci
succe tom mielk retir role year
compani year lead legal function melucci join compani
led global legal oper serv
compani corpor secretari respons lead
intern legal team prior join melucci held
seri gener counsel oper role
year global leadership experi drive win busi
et cfra keep hold opinion share
corpor keep target price-to-earnings
line kmb averag ep estim
trim ep estim ep
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
